Genetic factors play an important role in the aetiology of bipolar affective disorder (BP). So far, results oflinkage studies have been largely disappointing. We have searched for a possible association between polymorphic DNA markers of two candidate genes (tyrosine hydroxylase, TH; dopamine D2 receptor gene, DRD2) and BP in a population from central Spain. Our results are consistent with the existence ofa weak association between these two genes and BP, in such a way that TH and DRD2 could be considered as minor genes contributing to susceptibility.
Bipolar affective disorder (BP) is a major psychiatric disorder characterised by phases of mania or hypomania alternating with major depressive episodes, which afflicts an estimated 1% of the world's population.' Accumulated evidence from family, twin, and adoption studies have shown that genetic factors play an important role in the aetiology of the illness.2 Lod scores suggesting linkage have been reported using markers on the short arm of chromosome 1I,' as well as on the long arm of the X chromosome. 4 However, these initial reports have not been reproduced,5-" and the finding of a major gene remains elusive. This failure has been attributed to genetic heterogeneity, diagnostic uncertainties, or a not well established mode of inheritance. '2 In complex diseases, such as major psychoses, the use ofthe linkage analysis strategy in the search for susceptibility gene(s) has several drawbacks which have been pointed out elsewhere.'3 A strategy additional to linkage analysis in the study of BP is based on studies of association with candidate genes, in which the frequency of an allele at the marker locus in controls is compared with that of the patients.'"'6 Allelic association may be the result of (1) the existence of a disease locus physically close to the marker locus (linkage disequilibrium, that is, recombination frequency <1%), or (2) the marker allele itself is involved in disease risk.
Tyrosine hydroxylase (TH) and the dopamine D2 receptor gene (DRD2) may be considered as good candidate genes for conferring susceptibility to BP. It has long been suggested that a dysfunction of the catecholaminergic system may be involved in the pathogenesis of affective disorders,' and tyrosine hydroxylase is a rate limiting enzyme in the synthesis of catecholamines. In addition, Leboyer et all7 reported an association between TH polymorphisms and BP in a French population. On the other hand, it is known that the dopamine antagonists are effective in the acute management of manic phases in bipolar patients, and dopamine agonists seem to be effective antidepressants in some bipolar patients.' The dopamine D2 receptor is the major site of action of the neuroleptic haloperidol. Furthermore, three pedigrees have been reported in which translocations close to the chromosomal location of the DRD2 cosegregate with major psychiatric illnesses.1 '20 We have searched for a possible association between highly polymorphic DNA markers from these two genes and BP in a population from central Spain.
Material and methods

SUBJECTS
We have tested a total of 64 unrelated bipolar affective disorder patients (27 males and 37 females) ascertained at random from admissions to the Psychiatric Service of the Hospital Ramon y Cajal, Madrid, Spain. All of them were diagnosed using the DSM-III-R criteria2' on the basis of a structured interview, the Structured Clinical Interview for DSM-III-R (SCID),22 without knowledge of genotypes (by CL and JSR,2 both experienced clinicians). All bipolar probands met Research Diagnostic Criteria (RDC)23 for bipolar I (45 subjects) and bipolar II (19 subjects). The patients with schizoaffective disorder were not included in the study. Thirty-three patients (16 males and 17 females) had a family history of affective disorder. The family history was detected using the Family History -Research Diagnostic Criteria (FH-RDC). Forty-nine unrelated subjects (24 males and 25 females) without affective disorder in their family history (defined by affectedness of at least one first degree relative) were recruited from the resources of the Fundacion Jimenez Diaz, Madrid, Spain, as control probands. All patients and controls were ethnically white and living in central Spain. The mean ages of the two groups were: controls 40-2 years (SD 12-4), affected subjects 47-1 years (SD .
Pirez de Castro, Santos, Torres, Visedo, Saiz-Ruiz, Llinares, Fernmndez-Piqueras TH-DRD2 genotypes were pooled in three classes: (A) subjects with at least one copy of both thlO and C3 alleles, (B) subjects with at least one copy of the thlO or the C3 allele, and (C) subjects without thlO and C3 alleles. The comparison of the panients and controls for these classes showed significant differences (X'= 638, df=2, p<O05).
for continuity=4 59, df= 1, p< 05 A total of 45 controls (22 males and 23 females) and 46 patients (17 males and 29 females) were simultaneously genotyped for TH and DRD2 polymorphisms. All possible TH-DRD2 genotypes were pooled in three classes which were informative for the presence or absence of the alleles thlO and C3 (table 3) . The comparison of the tested populations for these classes showed significant differences. The number of subjects with at least one copy of each susceptibility allele (class A) was higher in patients (0 478) than in controls (0.244), while those with at least one copy of C3 or thlO allele (class B), and those without either of the two susceptibility alleles (class C) were more frequent in controls (0-622, 0-113, re- spectively) than in patients (0478, 0 043, respectively) (fig 2) . Similar results were obtained when the subpopulation of patients with a family history was exclusively considered (data not shown).
Discussion
Initial reports suggesting the involvement of the TH gene in the aetiology of BP have not been reproduced, either by linkage studies (as was mentioned in the introduction to this article) or by association analyses. 12 2311 Negative results have been also obtained with regard to the DRD2 gene. 1132-35 However, weak associations of the type we are reporting for TH and DRD2 are very difficult to show by linkage studies, as these analyses assume the existence ofa major susceptibility locus, but do not detect the presence of minor modifying genes.'4 In fact, TH and DRD2 have been proposed as modifying genes9 36 but negative results obtained from genetic association studies could be interpreted if one assumes the existence of genetic heterogeneity.
An advantage ofassociation studies, the strategy used in our work, is that no assumptions need to be made about the mode ofinheritance, penetrance, and age of onset of the disease. However, association studies have shown some limitations concerning the size and the stratification of the samples. In this study the stratification has been discarded because both test groups have been matched both for age and ethnic origin.
Regarding the distribution of alleles of the TH and DRD2 polymorphisms, we have found significant differences between control subjects and bipolar affective disorder patients. This result may be interpreted as an association between these genes and BP in our sample. It is worth mentioning that, although a positive association between TH and BP has been previously reported by Leboyer et al, '7 this is the first study in which a positive association between DRD2 and BP has been described.
The C3 and thlO alleles were significantly more frequent among patients than controls, even though the relative risk values of these genes suggests a weak association (4-147 for C3 and 2-33 for thlO). Hence, these could be considered as minor genes involved in the aetiology of this illness. When the relative risk values were corrected by multiplying by the number of polymorphisms, these values were not significant. However, correction for multiple comparisons is a controversial matter since reducing the type I error for null associations increases the type II error for those that are not null.37 This undesirable effect could be especially important in our study because the association between TH and DRD2 polymorphisms and BP seems to be moderate in this sample. Furthermore, this correction may be performed to test whether there is an overall association between alleles of a gene and the illness, but not when one wants to test whether there is an association between particular alleles of this gene and the illness, after the demonstration of the overall association com-paring the distribution of alleles between controls and patients, as performed in our study. On the other hand, the weakness of the association could be because of recombination between these polymorphisms and the mutations responsible for the disease.
Another intriguing finding was that subjects who simultaneously exhibited thlO and C3 alleles were significantly more frequent among patients than among controls. It could be argued that these genes code for two proteins involved in the dopaminergic system. TH catalyses the synthesis of L-Dopa from tyrosine, and L-Dopa is the precursor of catecholamines as dopamine. Thus, alterations in TH could be involved in unbalancing of the normal dopamine production. In addition, modifications of the dopamine receptors, such as DRD2, could be interfering with transmission at dopaminergic synapses in the brain. In the face of these assumptions, the simultaneous implication in most patients of both genes could be in agreement with the existence of an oligogenic model for the illness as has been suggested previously. Moreover, the weakness of the associations indicates that they should be minor genes which behave as additive or modifier genes. However, epistatic interactions cannot be ruled out.
Genetic association with BP was also sought in this sample using the dopamine D4 receptor (DRD4) and oc3 subunit ofthe GABAA receptor (GABRA3) as candidate genes, but we found no evidence of a positive association38 (Puertollano et al, submitted for publication).
These results provide some evidence for the involvement of dopaminergic systems in the aetiology of manic depression. It remains to be seen whether this hypothesis holds in more extensive studies.
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